Iizuka, Takahiro <br/><br/>
Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients.  [electronic resource] 

 -  Climacteric : the journal of the International Menopause Society  Aug 2008 
 - 287-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1473-0804 
<br/><br/><label>Standard No.: </label>10.1080/13697130801959590  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Alendronate--administration & dosage<br/>Alkaline Phosphatase<br/>Asian People<br/>Biomarkers--urine<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Remodeling--drug effects<br/>Bone Resorption<br/>Bone and Bones--enzymology<br/>Collagen Type I--urine<br/>Etidronic Acid--administration & dosage<br/>Female<br/>Humans<br/>Osteogenesis--drug effects<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Parathyroid Hormone--blood<br/>Peptides--urine<br/>Prospective Studies<br/>Risedronic Acid